Lucintel Forecasts The Global Agoraphobia Market To Reach $2 Billion By 2030

By Author: Lucintel LLC
Total Articles: 6657
Comment this article

According to a market report by Lucintel, the future of the global agoraphobia market looks promising with opportunities in the hospital, clinic, and academic markets. The global agoraphobia market is expected to reach an estimated $2 billion by 2030 with a CAGR of 6.3% from 2024 to 2030. The major drivers for this market are rising rates of panic and anxiety disorders, growing need for patient-centered, individualized treatment for mental health issues, as well as, increasing acceptance of virtual reality exposure treatment.
A more than 150–page report is developed to understand Trends, opportunity and forecast in agoraphobia market to 2030 by drug treatment (selective serotonin reuptake inhibitor, norepinephrine reuptake inhibitor, anti-anxiety medication, and others), therapy (psychotherapy, cognitive behavioral therapy, exposure therapy, and others), end use (hospital, clinic, academic, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
In this market, selective serotonin reuptake inhibitor, norepinephrine reuptake inhibitor, and anti-anxiety medication are the major segments ...
... of agoraphobia market by drug treatment. Lucintel forecasts that selective serotonin reuptake inhibitor will remain the largest segment over the forecast period because SSRIs is useful in relieving anxiety associated with agoraphobia, assisting patients in better managing stressful circumstances.
Within this market, hospital will remain the largest segment.
Download sample by clicking on agoraphobia market
North America will remain the largest region over the forecast period due to increase in the frequency of agoraphobia among the region's population.
Eli Lilly and Company, GlaxoSmithKline, Pfizer, AstraZeneca, Bristol-Myers Squibb Company, Johnson & Johnson, Lundbeck, Takeda Pharmaceutical, Mylan Pharmaceuticals, and Apotex are the major suppliers in the agoraphobia market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1 972.636.5056
Explore Our Latest Publications
Membrane Structure Market in Canada
Metal forming Machine Tool Market in Canada
Methylal Market in Canada
Neodymium Magnet Market in Canada
Non-Tyre Rubber Market in Canada